In-Transit Metastasis of Cutaneous Melanoma
2 clinical trials · Condition
◉ Watch In-Transit Metastasis of Cutaneous Melanoma
| Record | Firm | Date |
|---|---|---|
| (Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma (NCT05767879) | Leiden University Medical Center | 2022-01-01 |
| Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases (NCT03754140) | Melanoma Institute Australia | 2020-05-20 |
Track In-Transit Metastasis of Cutaneous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.